Butylated Hydroxyanisole (BHA) (CAS NO : 25013-16-5)

Butylated hydroxyanisole (CAS 25013-16-5) remains a cornerstone synthetic antioxidant in the high purity fine chemicals market, where American manufacturers prioritize its stabilization of lipid-containing food matrices and cosmetic formulations against oxidative degradation. 2-tert-Butyl-4-methoxyphenol has become a focal point for bulk chemical supplier strategies in the United States following the FDA's 2026 announcement of a comprehensive post-market safety reassessment, a move that is driving significant investment in custom synthesis services to ensure analytical compliance with evolving regulatory standards. BHA continues to be a critical technical additive for domestic CDMOs specializing in animal nutrition and pharmaceutical excipients, where the shift toward domestic supply chain resilience necessitates rigorous quality control via HPLC to maintain competitive purity profiles and satisfy heightened scrutiny from the Make America Healthy Again (MAHA) initiative. As an established Butylated HydroxyAnisole (BHA) supplier with Butylated HydroxyAnisole (BHA) >= 99% purity in the united states of america, we ensure dependable supply, consistent quality, and complete regulatory documentation, including Butylated HydroxyAnisole (BHA) CoA and TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and nationwide supply chain capabilities and logsitics coordination on all the 50 united states.